# Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers

> **NCT01525147** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 49 (actual)

## Conditions studied

- Rheumatic Arthritis

## Interventions

- **BIOLOGICAL:** YHB1411-2: Level 2
- **BIOLOGICAL:** YHB1411-2: Level 3
- **BIOLOGICAL:** YHB1411-2: Level 4
- **BIOLOGICAL:** YHB1411-2: Level 5
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** YHB1411-2: level 1

## Key facts

- **NCT ID:** NCT01525147
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-11
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2014-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01525147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01525147, "Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01525147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*